Interferon alfa-2b biosimilar (Getz Pharma)

干扰素α-2b生物类似药（Getz Pharma）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (Getz Pharma)
Drug Alias NameInterferon alfa 2b follow-on biologic (Getz Pharma)Uniferon
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGetz Pharma
China Registration ClassN/A

Develop Information

Active CompaniesGetz Pharma
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A